Proceedings (Aug 2019)
Repositioning of Dantrolene as a Multitarget Agent for Neurodegenerative Diseases
Abstract
Dantrolene is an orphan drug representing the sole therapeutic treatment for malignant hyperthermia, a life-threatening pathology affecting 0.2 in every 10,000 people in the EU. [...]
Keywords